Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.

Sekaggya-Wiltshire, Christine; Castelnuovo, Barbara; von Braun, Amrei; Musaazi, Joseph; Muller, Daniel; Buzibye, Allan; Gutteck, Ursula; Henning, Lars; Ledergerber, Bruno; Corti, Natascia; Lamorde, Mohammed; Fehr, Jan; Kambugu, Andrew

Sekaggya-Wiltshire, Christine; Castelnuovo, Barbara; von Braun, Amrei; Musaazi, Joseph; Muller, Daniel; Buzibye, Allan; Gutteck, Ursula; Henning, Lars; Ledergerber, Bruno; Corti, Natascia; Lamorde, Mohammed; Fehr, Jan; Kambugu, Andrew.

Afiliación

Sekaggya-Wiltshire C; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Castelnuovo B; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
von Braun A; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Musaazi J; Division of Infectious Diseases and Infection Control, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Muller D; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Buzibye A; Department of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Gutteck U; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Henning L; Department of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Ledergerber B; Division of Infectious Diseases and Infection Control, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Corti N; Division of Infectious Diseases and Infection Control, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Lamorde M; Division of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Fehr J; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Kambugu A; Division of Infectious Diseases and Infection Control, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

BMJ Open ; 7(9): e014679, 2017 09 18.

Article en En | MEDLINE | ID: mdl-28928173

Asunto(s)

Antirretrovirales/sangre; Antituberculosos/sangre; Infecciones por VIH/tratamiento farmacológico; Proyectos de Investigación; Tuberculosis Pulmonar/tratamiento farmacológico; Adulto; Antirretrovirales/uso terapéutico; Antituberculosos/farmacocinética; Antituberculosos/uso terapéutico; Investigación Biomédica/métodos; Recuento de Linfocito CD4; Estudios de Cohortes; Coinfección/sangre; Coinfección/tratamiento farmacológico; Combinación de Medicamentos; Etambutol/sangre; Etambutol/farmacocinética; Etambutol/uso terapéutico; Femenino; Humanos; Isoniazida/sangre; Isoniazida/farmacocinética; Isoniazida/uso terapéutico; Masculino; Pirazinamida/sangre; Pirazinamida/farmacocinética; Pirazinamida/uso terapéutico; Rifampin/sangre; Rifampin/farmacocinética; Rifampin/uso terapéutico; Tuberculosis Pulmonar/sangre; Uganda

Palabras clave

anti-tuberculosis drugs; cohort; pharmacokinetics; set-up; therapeutics; tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proyectos de Investigación / Tuberculosis Pulmonar / Infecciones por VIH / Antirretrovirales / Antituberculosos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: BMJ Open Año: 2017 Tipo del documento: Article País de afiliación: Uganda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google